Tucking In?

UK surgeons suggest that increases in slimming jabs, might well result in more people subsequently travelling overseas, to remove their surplus skin (https://www.theguardian.com/science/2023/mar/25/slimming-jabs-overseas-trips-to-remove-excess-skin-uk-surgeons-warn). Liraglutide and Semaglutide are both being made available on the UK's National Health Service (NHS). Weekly injections of these compounds, suppresses appetite and can reduce people's weight by more than 10%. After the Covid19 pandemic and strikes, the NHS has a considerable work backlog. Tummy tucks and other largely cosmetic procedures, are not seen as priorities. People might consequently have to travel abroad for private treatments, to remove unsightly folds of skin. This could result in more work for the NHS, if people come back with infections or botched operations.